Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis
Head and neck squamous cell carcinomas (HNSCCs) contribute to over 300,000 deaths every year worldwide. Although the survival rates have improved in some groups of patients, mostly due to new treatment options and the increasing percentage of human papillomavirus (HPV)-related cancers, local recurre...
Main Authors: | Zuzanna Nowicka, Konrad Stawiski, Bartłomiej Tomasik, Wojciech Fendler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/19/4799 |
Similar Items
-
The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
by: Marieke Bamps, et al.
Published: (2021-07-01) -
Serum-free media supplements carry miRNAs that co-purify with extracellular vesicles
by: Martin Auber, et al.
Published: (2019-12-01) -
Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis
by: Jeong-Wook Kang, et al.
Published: (2021-06-01) -
The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer
by: Lily Nguyen, et al.
Published: (2020-12-01) -
Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status
by: Christine Goudsmit, et al.
Published: (2021-07-01)